Moreover, ILK expression has an impact on ErbB2-driven mammary tumor onset, and disruption of ILK inhibits proliferation and invasion and sensitizes ErbB2 tumor cells to apoptotic cell death [42]. This evidence concerns the gene ERBB2 and breast cancer.